Researchers from North Carolina State University have found that multiple species of Gardnerella, bacteria sometimes associated with bacterial vaginosis (BV) and pre-term birth, can coexist in the same vaginal microbiome. The findings add to the emerging picture of Gardnerella’s effects on human health.
read moreA new research study indicates the presence of specific bacteria in the eye microbiome is correlated with dry eye symptoms.
read moreA new study indicates the presence of specific microbiota strains can predict response to immune checkpoint blockade.
read moreA team of researchers found that the presence and abundance of certain gut bacteria varied with the participants’ emotional states. Those who reported higher levels of positive emotions had different bacterial compositions compared to those who reported higher levels of negative emotions.
read moreA new study shows that symptomatic infections with H. pylori after the age of 50 can be associated with an eleven percent increase in the risk of Alzheimer's disease. The risk increase peaks at 24 percent about a decade after the initial infection.
read moreA recent study evaluated stool samples of patients with severe COVID-19 infections in the ICU. Results demonstrated that these patients had lower microbiome diversity, indicating a potential biomarker of disease progression and severity.
read moreA new study from researchers at the RIKEN Center for Integrative Medical Sciences (IMS) in Japan reports the discovery of an order of gut bacteria that may help protect against type 2 diabetes and obesity by improving insulin resistance.
read moreA French Documentary series, The Extraordinary Powers of the Human Body produced by Elephant / 17 Juin Media highlights the University of Minnesota Microbiota Therapeutics Program in Episode 4 "Stomach aches, depression, cancers: the microbiota revolution." View the entire episode or watch the University of Minnesota segment at 1 hour 20 minutes. The segment shares the microbiota transplant therapy used for C. difficile patients, highlights Amanda Kabage's healing experience after receiving a microbiota transplant and the process of creating microbiota therapeutics from donor to capsule.
read moreIn this first-ever, double-blind clinical trial, ASU researchers demonstrated that microbiota transplant therapy, which first uses antibiotics to eliminate bad bacteria from the intestines and then replaces it with healthy bacteria, reduces gastrointestinal symptoms and other symptoms in people with autism, as well as in children with Pitt-Hopkins.
read moreA study at the University of Minnesota, supported by Achieving Cures Together, indicated Microbiota Transplant Therapy is safe in patients with acute myeloid leukemia and undergoing stem cell transplantation. In the randomized, double blind study, patients enrolled in the active treatment group received microbiota therapeutics after each round of antibiotics. Trial results indicate that patients receiving microbiota transplant therapy had reduced rate of infection compared to patients receiving the placebo, while not statistically significant.
read more
